CV Sciences, Inc. (OTCMKTS:CVSI) Sees Large Drop in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSI) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 9,800 shares, a decline of 54.8% from the October 15th total of 21,700 shares. Based on an average daily volume of 550,900 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Performance

CVSI remained flat at $0.04 during trading on Friday. 264,425 shares of the company traded hands, compared to its average volume of 281,686. The company has a market cap of $7.80 million, a P/E ratio of -4.22 and a beta of 0.59. CV Sciences has a 52 week low of $0.03 and a 52 week high of $0.10. The stock has a 50-day moving average price of $0.05 and a 200-day moving average price of $0.05.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.